Last quarter (Q4 2023), Caribou Biosciences's total revenue was $3.56M, a decrease of -3.63% from the same quarter last year. In Q4, Caribou Biosciences's net income was $-34.51M. See Caribou Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 34.48M	$ 34.48M	$ 13.85M	$ 9.60M	$ 12.36M	$ 5.79M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 34.48M	$ 34.48M	$ 13.85M	$ 9.60M	-	-
Operating Expense	$ 150.54M	$ 150.54M	$ -120.25M	$ -76.58M	$ 48.48M	$ 40.09M
Operating Income	$ -116.06M	$ -116.06M	$ -106.40M	$ -66.98M	$ -36.12M	$ -34.30M
Net Non Operating Interest Income Expense	$ 255.00K	-	$ 2.43M	$ -1.43M	$ 216.00K	$ 1.04M
Other Income Expense	$ -13.93M	$ -14.18M	$ -4.62M	$ -1.80M	$ -219.00K	$ 2.29M
Pretax Income	$ -101.88M	$ -101.88M	$ -99.35M	$ -66.60M	$ -36.13M	$ -30.97M
Tax Provision	$ 193.00K	$ 193.00K	$ 70.00K	$ 321.00K	$ -1.82M	$ -7.54M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -102.07M	$ -102.07M	$ -99.42M	$ -66.92M	$ -34.31M	$ -23.43M
Basic EPS	$ -1.45	$ -1.38	$ -1.64	$ -2.11	$ -1.51	$ -1.03
Diluted EPS	$ -1.45	$ -1.38	$ -1.64	$ -2.11	$ -1.51	$ -1.03
Basic Average Shares	$ 295.23M	$ 73.81M	$ 60.80M	$ 31.66M	$ 22.67M	$ 22.67M
Diluted Average Shares	$ 295.23M	$ 73.81M	$ 60.80M	$ 31.66M	$ 22.67M	$ 22.67M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 150.54M	$ 150.54M	$ -120.25M	$ -76.58M	$ 48.48M	$ 40.09M
Net Income From Continuing And Discontinued Operation	$ -102.07M	$ -102.07M	$ -99.42M	$ -66.92M	$ -34.31M	$ -23.43M
Normalized Income	$ -35.01M	$ -80.48M	-	-	$ -33.61M	$ -25.17M
Interest Expense	-	-	-	-	$ 20.00K	$ 4.00K
EBIT	$ -102.13M	$ -101.88M	$ -99.35M	$ -65.18M	$ -36.11M	$ -30.96M
EBITDA	$ -92.17M	$ -102.78M	$ -98.53M	$ -64.14M	$ -35.21M	$ -30.21M

Currency in USD

Caribou Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing